Developed by Navi Medical Technologies, Neonav uses real-time intravascular ECG to support central venous access device tip placement and ongoing migration surveillance. Alex Newton, Chief Executive Officer of Navi Medical Technologies, said: "Neonatal and paediatric clinicians have relied on technologies that were never designed for their smallest patients." Alex Newton, Chief Executive Officer of Navi Medical Technologies, said the funding would accelerate the company’s transition from clinical validation to commercialisation. Rod Bristow, CEO of Innovation Victoria, said the investment demonstrated the global potential of Australian medical technology innovation. About: Navi Medical TechnologiesFounded in Melbourne, Navi Medical Technologies develops next-generation vascular access technologies for neonatal and paediatric care.